Vaccination

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India ‘eliminate’ cervical cancer.

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

Cervical cancer rates are predicted to fall following the introduction of HPV primary screening this year.

The Joint Committee for Vaccination and Immunisation has recommended that boys are offered the HPV vaccine. We look at what this could mean and next steps.

A vaccine to prevent cervical cancer is safe and effective in reducing cell changes, a new review has confirmed.

Following our research on how lifestyle affects cancer risk, we look at how research into vaccines, screening and drugs could also help prevent cancers.

Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.